SB
Sushil Barhoi
About Sushil Barhoi
Data last updated:
Sushil Barhoi has 14 years in corporate governance. Holds Director role. Currently with 1 company, including Tezpur Institute Of Medical Sciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Tezpur Institute Of Medical Sciences Private Limited at ₹40.11 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tezpur Institute Of Medical Sciences Private Limited U85110AS2012PTC010927 | Director | 14 Feb 2012 | 2012 | ₹40.11 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushil Barhoi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushil Barhoi
Sushil Barhoi has 14 years in corporate governance. Holds Director role. Currently with 1 company, including Tezpur Institute Of Medical Sciences Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Tezpur Institute Of Medical Sciences Private Limited at ₹40.11 Cr (FY 2024).
Sushil Barhoi is associated with 1 company as Director, including Tezpur Institute Of Medical Sciences Private Limited (₹40.11 Cr).
Sushil Barhoi has expertise in General Business.
Sushil Barhoi has 14 years in corporate governance.
By reported revenue, the largest current company of Sushil Barhoi is Tezpur Institute Of Medical Sciences Private Limited, with revenue of ₹40.11 Cr (FY 2024).
Sushil Barhoi currently holds positions at 1 company: Tezpur Institute Of Medical Sciences Private Limited (₹40.11 Cr).